Skip to main content
. Author manuscript; available in PMC: 2009 Sep 22.
Published in final edited form as: Cancer Cell. 2007 Jan;11(1):83–95. doi: 10.1016/j.ccr.2006.11.021

Figure 6. Kaplan-Meier Survival Distributions.

Figure 6

(A) Progression-free survival and (B) overall survival in sixteen recurrent glioblastoma patients receiving AZD2171 (bold red lines) accompanied by upper and lower 95% confidence limits (thin black lines).